Marina Posts Higher Q4 Losses on Restructuring Charge
March 31, 2011
Marina Posts Higher Q4 Losses on Restructuring Charge
Following a stock offering in February, which raised $5.1 million, Marina said it has enough resources to fund operations into the second quarter of this year.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Marina, on Track with FAP Drug, Starts Looking to Raise Needed Cash
May 19, 2011 / Gene Silencing News - Marina Defaults on Loan as Bankruptcy Looms
January 31, 2013 / Gene Silencing News - Marina Extends Cash Runway to Year End, Sells Off Equipment
December 13, 2012 / Gene Silencing News - Debiopharm Drops Out of Bladder Cancer Deal with Cash-Strapped Marina
November 15, 2012 / Gene Silencing News - Marina Says Cash Will Run out at the End of the Month, Reports 2011 Financials
October 18, 2012 / Gene Silencing News